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Overviews (i.e. reviews of multiple systematic reviews) comprise a relatively novel methodology to 
systematically synthesise research findings.  Overviews aim for a beneficial impact on clinical practice, but 
their methods and pathways to impact have so far not been mapped. 
Aim 
To inform recommendations for optimising impact on rehabilitation practice and research by mapping 
methods and pathways to impact in Cochrane overviews relevant to rehabilitation.  
Methods 
We systematically searched and identified published Cochrane overviews (to June 2018) relevant to 
rehabilitation.  We extracted data and compared overviews on key characteristics, methods of evidence 
synthesis, statements about impact, and access metrics.  We explored one overview in detail regarding 
beneficiaries, activities and outputs, mapped potential pathways to impact, and, using an iterative process, 
refined this into a generic map. Through exploration of all synthesised data, we propose further 
recommendations for planning, conducting and reporting of future overviews in order to optimise impact 
on rehabilitation. 
Results 
We identified seven Cochrane overviews relevant to rehabilitation.  Their focus and methods varied, but 
they were broadly related to rehabilitation interventions for populations of people with diverse long term 
conditions.  Overviews also varied regarding their intended impact; only 4 overviews identified specific 
beneficiaries. All overviews included multiple tables and figures, but only one synthesised key findings into 
a single figure. For five overviews, the Altmetric Attention Score (a weighted count of attention that an 
output receives based on a range of online sources) was in the top 5% of all research outputs scored by 
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Altmetric.  The overview within our worked example had four key impact goals, each with different 
beneficiaries and required actions; this example led to a generic map of potential pathways to impact for 
other overviews. 
Conclusions 
Cochrane overviews have the potential to play a key role in knowledge translation and therefore to be 
useful in supporting evidence-based rehabilitation practice.  However, current overviews relating to 
rehabilitation differ in methods, approaches and intended impact, and sometimes fall short of promoting 
easy access to key information for beneficiaries.  Future Cochrane overviews should address topics of 
importance to key beneficiaries and clearly outline potential pathways to impact in order to have a 
potential beneficial impact on evidence-based rehabilitation and to improve rehabilitation outcomes. 
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Systematic reviews use established, robust research methods to find and bring together, in an explicit and 
transparent way, all the research evidence that addresses a particular topic or question.  In the field of 
health and social care, by systematically and comprehensively identifying, appraising and synthesising 
evidence relating to the effectiveness of interventions, systematic reviews are considered to play a central 
role in informing and supporting evidence-based practice.1  High quality systematic reviews which 
aggregate (i.e. statistically combine using meta-analysis) data from a number of similar studies are widely 
recognised to provide the best source of evidence to inform decision making.2, 3  The publication rate of 
systematic reviews of healthcare interventions is rapidly increasing;4 in 2014 it was estimated that >8000 
systematic reviews were indexed on MEDLINE and that around 22 new systematic reviews were being 
published every day.5  In August 2018 there were 9471 Cochrane systematic reviews and protocols 
available within the Cochrane Library of which 9.4% (894) were directly relevant to rehabilitation.6 
While high quality systematic reviews are desirable and potentially beneficial to the delivery of optimal 
healthcare interventions, including rehabilitation, the rapidly increasing number of systematic reviews can 
be overwhelming for healthcare decision makers.7, 8  In response to this, systematic reviews of systematic 
reviews are being produced, using new and evolving methodologies.9-11  These are referred to as 
“overviews” (or sometimes also “umbrella reviews” or “meta-reviews”), and involve systematically 
identifying, appraising and synthesising the results of multiple systematic reviews in order to inform and 
support decision making.10, 12-15    
Overviews generally have a goal of providing a summary of evidence, signposting evidence within 
systematic reviews in order to support healthcare decision making, although there can be considerable 
variation in the specific aims of individual overviews.10, 15, 16  Overviews generally address broader research 
questions than systematic reviews,17 exploring the effects of different interventions for the same 
population or problem17, 18 or the same intervention for different populations or problems.18, 19  Overviews 
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may examine reasons for discordant review findings20, 21 and/ or identify research gaps.18, 21  By fulfilling 
these various aims, overviews can effectively summarise the known evidence relating to a broad topic or 
issue, and can play a key role in directing healthcare decision makers to sources of more detailed 
information, including systematic reviews and primary research.21-24 Further, overviews have been 
proposed to play an important role in the avoidance of research waste.17 
Overviews are a new and developing methodology and there is currently considerable variation in their 
methods.  While some of the methods for overviews are shared with established methods for systematic 
reviews,25 there are unique methodological challenges within overviews for which best practice has not yet 
been established.14, 16, 21, 22, 26-28  Recent evaluations have highlighted inconsistencies and gaps in current 
guidance for methods for conducting overviews14, 16, 26 and lack of evidence to support selection of optimal 
methods for individual overviews.16, 25  Work is underway to summarise current evidence and develop 
guidance relating to the conduct and reporting of overviews.16, 25, 29, 30  
Cochrane Rehabilitation aims to ensure that rehabilitation professionals have the best-available 
information to support evidence-based practice.31  Overviews of rehabilitation reviews may be able to 
support this aim, although the potential pathways from overview to impact are currently unclear.  The term 
“impact” may be interpreted in different ways, and can incorporate academic advances, or societal or 
economic contributions, which relate to improving practice;32 Cochrane Rehabilitation’s knowledge 
translation strategy ultimately aims for evidence from Cochrane reviews to have an impact on decision-
making in rehabilitation.33, 34   For the purpose of this paper, we defined “impact” according to the Research 
Councils in the UK: academic impact is defined as “the demonstrable contribution that excellent research 
makes to academic advances, across and within disciplines, including significant advances in understanding, 
methods, theory and application”, while societal and economic impact is defined as “the demonstrable 
contribution that excellent research makes to society and the economy”.32  Using these definitions, we 
considered that the impact of an overview could be expressed as academic advances conveyed in outputs, 
such as publications, as well as changes that happen in the real world (beyond the world of researchers).35  
The goal of this paper is to explore how Cochrane overviews of reviews may generate impact, both on 
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clinical decision making in rehabilitation (i.e. societal/ economic impact) and research (i.e. academic 
impact).  The specific aims are to:  
1. Describe, compare and contrast key features of published Cochrane overviews relevant to 
rehabilitation, i.e. methodological characteristics (such as selection criteria, data extraction and 
reporting) and statements of intended impact; 
2. Discuss the potential role of Cochrane overviews in supporting evidence-based rehabilitation by 
exploring the anticipated impact of one Cochrane overview as a worked example; 
3. Provide recommendations for optimising the impact arising from Cochrane overviews. 
MATERIALS AND METHODS 
We systematically searched for and identified published Cochrane overviews relevant to rehabilitation, and 
extracted and synthesised data relating to key methodological characteristics and expressions of 
anticipated impact (on practice and research) of these overviews.  We conducted additional data extraction 
and evaluation relating to the outputs and impact of one overview which we had authored, to stimulate 
discussion on generating impact based on a worked example.  Emerging findings, relating to methods, 
output and impact of overviews, informed a discussion about the role of Cochrane overviews in evidence-
based rehabilitation.  Based on this, a number of recommendations for optimising the impact of Cochrane 
overviews were proposed, which are illustrated in a model.  Key stages are described below: 
Search methods 
We searched the Archie database, version 4.18 on 18th June 2018; Archie is Cochrane’s central system for 
Cochrane authors and review groups, enabling management of individual reviews and portfolios of reviews 
by review groups.  We used the “Advanced Search” function, searching documents for reviews of type 
“overviews of reviews” and with a publication status of “published”.  We exported the search results into 
Excel.  To be included the following criteria had to be met: full published overview, synthesising evidence 
relating to one or more rehabilitation interventions.  We used the WHO definition of rehabilitation: 
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“Rehabilitation is characterized by interventions that address impairments, activity limitations and 
participation restrictions, as well as personal and environmental factors (including assistive technology) 
that have an impact on functioning”.36  Two authors independently applied the inclusion criteria, with any 
disagreements resolved through discussion.  First, each author independently screened the titles and 
excluded any overviews judged to be focussed only on pharmacological or surgical interventions.  Second, 
each author independently assessed abstracts and, if necessary, full papers for all remaining titles.  At this 
stage published protocols, which were not yet completed, and overviews which had been withdrawn from 
publication were excluded.  All remaining overviews were assessed to determine if they met the criterion of 
synthesising systematic review evidence focussed on one or more rehabilitation interventions.  Reasons for 
excluding overviews, any disagreements between authors and final consensus decisions were documented.  
Data extraction 
For all included overviews we systematically documented key methodological characteristics, using 
headings previously adopted to describe overview methods.21  These included: aim/question of overview, 
inclusion criteria (participants, interventions, outcomes, type of study), databases searched, any updating 
of out of date reviews, methods of selecting reviews, data extracted, tool or method for assessing quality of 
reviews, approach or method for assessing quality of evidence within reviews, description of how evidence 
was synthesised, details of any statistical analyses (planned or carried out), and description of how key 
findings were presented.  For each included overview we extracted key results data, including: number of 
included reviews, number of reviews with data extracted (and whether these were Cochrane or non-
Cochrane reviews), number of included primary studies (in the overview), number of RCTs and participants 
within included reviews, and the number of included reviews directly relevant to rehabilitation. 
To explore the intended impact of the included overviews we sought and extracted information relating to 
different types of impact.  For societal/ economic impacts, we extracted statements about the purpose of 
the overview relating to rehabilitation practice, and any statements on the anticipated implications of the 
findings for practice.  For academic impacts, we extracted statements about the purpose of the overview 
relating to research, and any statements on the anticipated implications for research.  Further, as the 
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purpose of overviews has been described as “mapping”16, 23, 37 or “sign-posting”11, 18, 21 evidence, broadly 
referring to the act of “summarising broad issues and current knowledge around a topic, and directing a 
reader to more detailed, fine-grained material contained in component systematic reviews and primary 
research”11 we documented in what way this was done.  
To measure academic impact in terms of the uptake of the overviews, we extracted data relating to article 
metrics, including the number of times the overview was cited (via Web of Science,  
https://clarivate.com/products/web-of-science), the Altmetric Attention Score (a weighted count of all the 
attention a research output receives based on number of mentions within a range of online sources 
including public policy documents, media outlets, blogs and social media posts) (www.altmetric.com) and 
the number of full-text downloads during 2016 (from a summary of review metrics produced by 
Cochrane38).  
Data synthesis 
For all included overviews, we summarised the extracted data within tables, and produced a narrative 
account highlighting key differences and similarities in the methods of the included overviews, and their 
descriptions of intended impact. 
We then selected one overview, completed by the author team,39 in order to allow a more in-depth 
exploration of its impact, including both impact on practice and on research.  We reached consensus on 
impact goals, based on goals stated within the published overview.  We noted the potential beneficiaries of 
each of our identified impact goals, and evidence of any specific activity or output which demonstrated 
achievement of the impact goal.  For academic impact, we extracted evidence directly attributed to this 
overview from the ResearchFish Database (https://www.researchfish.net/), which contained routinely 
collected details of the outputs arising from this overview, updated on an annual basis from 2014 (last 
update March 2018).   
Based on impacts identified through the worked example, we used definitions of impact types, from UK 
Research Excellence Framework,32, 40 to inform the development of a generic map of potential pathways to 
9 
 
impact from Cochrane overviews in the field of rehabilitation. This involved an iterative process; we first 
mapped the impact goals, beneficiaries and intended actions from the worked example, which was specific 
to arm recovery in people after stroke. We considered each of the outputs listed within the ResearchFish 
database and entered these into a draft visual representation of the pathways to impact.  Next we 
discussed the wider implications of the mapped pathways to impact relating to our worked example, 
specifying in generic language the intended types of impact, beneficiaries and actions required, and their 
interaction.  Further discussion and refinement led to a generic map of proposed pathways to impact for 
any Cochrane overview in the field of rehabilitation. 
We conclude this paper with a narrative discussion exploring the potential impact of Cochrane overviews 
on the delivery of evidence-based rehabilitation, including research to provide new evidence, using earlier 
results to support key points.  We propose a number of recommendations for optimising the potential to 
achieve a beneficial impact from Cochrane overviews on rehabilitation.  
RESULTS 
Results of the search 
We considered 59 published Cochrane overviews; seven met our criteria for being a published Cochrane 
overview relevant to rehabilitation,39, 41-46 and were included (see Figure 1, and Table of excluded overviews 
(Supplementary Digital Material: Appendix 1)). 
Cochrane overviews relevant to rehabilitation 
(1)  Overview methods 
Table I provides a summary of key characteristics of the methods of the included overviews.   All seven of 
the overviews aimed to summarise evidence relating to the effectiveness of a group of interventions for a 
specific population of participants (see Table I for details).   Three of the seven overviews were focussed 
specifically on rehabilitation interventions,39, 41, 42 while four considered a broad range of different types of 
intervention (i.e. pharmacological and/or surgical, as well as rehabilitation interventions).43-46  Five of the 
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overviews pre-stated outcomes of interest;39-44 one overview included any outcomes as reported in the 
individual Cochrane reviews, and categorised these according to the ICF;45 and one overview defined 
outcomes of interest within the methods but did not report data relating to these, instead narratively 
reporting outcomes reported in individual trials.46  All overviews reported adverse events, where this 
information was reported in their included studies.  Only three overviews  included outcomes relating to 
costs or cost-effectiveness.41, 45, 46 
Search strategies, and actions relating to how up-to-date reviews were, varied across the included 
overviews. Three of the overviews only included Cochrane reviews and, within these, searching was limited 
to the Cochrane Database of Systematic Reviews (CDSR), withno action taken to update searches of 
Cochrane reviews which were out of date.41, 42, 44  Three of the overviews searched for non-Cochrane 
reviews in addition to Cochrane reviews, searching a number of electronic databases in addition to CDSR;39, 
44, 46 despite searching, one of these overviews46 did not include any non-Cochrane reviews.  Two overviews 
searched multiple electronic databases for randomised controlled trials, in addition to searching for 
Cochrane43 and non-Cochrane reviews46, in order to identify any trials which were not included within a 
review.   
The inclusion of non-Cochrane reviews in addition to Cochrane reviews introduces methodological 
challenges associated with how to deal with issue of overlapping reviews (i.e. two or more reviews 
synthesising the same, or similar, evidence).  The approach taken within the two overviews including non-
Cochrane reviews differed; one selected the most up-to-date (and high quality) evidence, after appraisal of 
both Cochrane and non-Cochrane reviews,39 while the other only sought a non-Cochrane review which was 
more up-to-date than a Cochrane review on the same topic.44   One overview avoided the issue of overlap 
by only including Cochrane reviews, and addressed the issue of up-to-dateness by supplementing included 
Cochrane reviews with randomised controlled trials which were published after the search date of the 
Cochrane review, identified through searching the review group trials register.43 The overview authors 
stated that they originally planned to “update Cochrane reviews with new studies identified for inclusion”, 
but found there were challenges which precluded them from doing this.43  There were similarities in the 
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selection methods for all overviews, with – as is considered appropriate within systematic review 
methodology – two independent authors applying inclusion criteria to identify relevant reviews.  However, 
this approach was not used for the selection of trials within the overview including primary studies, where 
only one author was involved in trial selection.43 
Six of the seven overviews extracted and reported key characteristics of the included reviews, such as 
inclusion criteria, search strategies, and some details pertaining to the review results (e.g. number of 
included studies, participant demographic variables).39, 41-45  One of the overviews also extracted data 
relating to the individual trials included in the reviews.41 The seventh overview identified RCTs included 
within the reviews and extracted and reported (limited) characteristics of these, without describing the 
characteristics of the reviews.46  Five of the overviews systematically extracted the results of meta-analyses 
in the review, where these had a relevant intervention and outcome, and reported these results within a 
series of detailed tables.39, 41-44  One overview presented results in a narrative format, without systematic 
extraction of meta-analysis results,45 while one focused on the results of the included trials rather than 
reporting any results from the individual reviews46. 
Quality assessment methods showed similarities, with all seven of the overviews using two independent 
authors using the AMSTAR (or a modified version) to assess quality of the review methods.  Six of the seven 
overviews used the GRADE approach to assess the quality of evidence within the reviews, with two using 
explicit/objective criteria to inform downgrades.39, 44  One overview grouped the quality of evidence in the 
included reviews into “tiers”, based on explicit criteria relating to methods, risk of bias and outcomes.42 
(2) Overview results  
Table II provides a summary of the quantity of evidence included within each overview.  This table also 
shows variation of sources included, with five overviews41-43, 45, 46 including only Cochrane reviews and two 
overviews39, 44 including both Cochrane and non-Cochrane reviews.  Six of the overviews reported the 
effects of interventions using a narrative account of the results of the reviews, supported by tables, whilst 
one46 focused on the results of the individual trials identified from the reviews.  There were differences in 
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the way in which results for the “effects of interventions” had been structured and presented, with two 
overviews structuring narrative summaries around each outcome of interest,42, 43 two overviews structuring 
narrative summaries around different interventions,39, 44 one overview grouping evidence according to 
whether interventions act at the level of “impairment” or “activity and participation”45, one overview 
describing the key results of each individual included review,41 and one overview describing the key results 
from individual trials.46   Five of the overviews summarised effect size data within tables.39, 41-44  There were 
similarities in tabulated data although differences in how this was presented, with reported data including: 
intervention, comparison, outcome, number of trials and participants, effect size, P-values and confidence 
intervals.   Two overviews illustrated effect size visually, within at least one forest plot.39, 44 One overview 
pooled the effect sizes for individual trials, using data extracted by overview authors from trials identified in 
reviews.44  In contrast, one overview plotted pooled effect size data as presented in different reviews in 
order to provide a visual representation of effect sizes for different interventions compared with control, 
for the same outcome measure.39  
(3) Overview impact  
Table III provides a summary of the intended impacts, reported within the overviews.   Intended 
beneficiaries were identified as clinicians,39, 45, 46 policy makers,39, 45 people with the condition,46 informed 
consumers,45 readers,44 and researchers.46 Three of the overviews did not seem to identify specific 
beneficiaries.41-43  Intended actions to generate impact on practice included directing readers,39, 44 aiding 
decision-making,39 providing evidence for intervention delivery,41 but such actions did not seem to be 
explicit in the remaining overviews.42, 43, 45, 46  Intended actions to bring about impact on research included; 
making recommendations for future research,39, 41-43, 45, 46 identifying opportunities for merging or splitting 
existing Cochrane reviews,41 making recommendations for the use of outcome measures for future 
research,43 evaluating the interpretation of the evidence in published reviews,42 whilst there appeared to 
be no mention of intended impact on research in the remaining overview.44   
The method for “signposting” or “mapping” varied widely, as Table III indicates.  All overviews aimed to 
synthesise information from different reviews, while four additionally stated that their purpose was to 
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produce an accessible (“usable” or “friendly front-end”) document.39, 41, 44, 45  All overviews included 
multiple tables and/ or figures, but only one39 included a single figure that listed each intervention, the 
quality of the underpinning evidence and key outcomes, together with the evidence source. 
The implications of findings for practice varied considerably, ranging from specific, evidence-based 
recommendations for treatment delivery39, 43 and confirmation of evidence supporting guidelines41 to calls 
for a cautionary approach given a lack of evidence.39, 42, 44, 45  One overview46 did not identify any reviews 
related to rehabilitation interventions and therefore no implications for practice or research could be 
extracted.  
The implications of the findings for research also varied, from general methodological recommendations to 
improve future research,41, 43, 44 specific recommendations for future reviews and/ or clinical trials,39, 42-44 
recommendations to establish a national/ international organisation around patient values to improve the 
evidence base,43 to develop an agreed, appropriate set of outcome measures42, 43, 45, 46 and time points,46 
and to cover the entire spectrum of care45 in future research.  Two overviews39, 44 also recommended 
collaborative working in future research, thereby avoiding research waste39 or improving recruitment.44  
One overview39 suggested that it could inform prioritisation of future research.  
(4) Overview Uptake 
The uptake of overviews, by different readers using different communication channels, can be captured in a 
range of metrics. Table IV summarises an array of different key access data for each of the seven overviews, 
illustrating substantial variation between them.   
Case study: Impact of Stroke Upper Limb Overview 
One overview39 was used as a worked example to explore impact on research and practice in more detail.  
Exploration of the stated aims and objectives of this overview39 led to consensus that there were four key 
impact goals, each with different potential beneficiaries.   
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These were: (1) Support decision making for stroke rehabilitation (beneficiaries: clinicians, service 
managers, policy makers), (2) Inform evidence-based practice through service design and/or delivery 
(beneficiaries: policy makers, professional bodies and networks, and governments), (3) Inform future 
research (beneficiaries: researchers and research funders), and (4) Improve outcomes and experiences for 
stroke survivors and their families (beneficiaries: patients, carers, families).     
Documented outputs (see Supplementary Digital Material: Appendix 2) suggest that evidence within the 
overview informed evidence-based clinical practice through impact on national guidelines (e.g. the 
overview is cited in RCP National Clinical Guideline for Stroke 201647), and informed parliamentary 
personnel following a presentation to national government (see “Engagement activities” in Appendix 2).  A 
series of presentations to health professionals working in stroke care, and the dissemination of a summary 
document signposting health professionals to relevant systematic reviews, was designed to impact on 
decision making of clinicians; feedback gathered from participants indicated that they intended to change 
their behaviour as a result of the information that they received but there was no formal evaluation of 
impact (see “Project details” in Appendix 2).  Primary research studies, subsequent to this overview, have 
cited research recommendations from the overview, evidencing academic impact (see “Subsequent 
funding” in Appendix 2).  The goal of improving stroke survivor outcomes was considered to be dependent 
on successful achievement of the previous three goals, but evidence of this impact is yet to be established. 
Towards a map of potential pathways to impact 
We mapped the pathways to impact from the above worked example, and then refined this into a generic 
map of potential impacts and pathways to impact for any overview on rehabilitation. This map is presented 
in Figure 2. 
DISCUSSION 
There are currently seven Cochrane overviews focussed on topics relevant to rehabilitation, although only 
six of these included evidence relevant to rehabilitation.  The focus and methods of these overviews vary, 
but they are broadly related to rehabilitation interventions for populations of people with diverse long term 
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conditions.  A stated aim of all of these overviews was to bring together and document evidence relating to 
a range of interventions, and all overviews included at least one summary table, providing access to (or 
“signposting” clinicians to) relevant evidence. However, while it was common for overviews to state that 
they aimed for an impact on evidence-based rehabilitation, their intended pathway to this impact was not 
always clear.  Similarly, most overviews (six out of seven) stated that they aimed to have an impact on 
research, either by identifying gaps in research or establishing recommendations for future research, but 
the intended pathway to this impact on research was not always clear; only three overviews explicitly 
described a method to determine research gaps or recommendations. There were some further differences 
between the stated purpose relating to impact on research, with some overviews stating additional aims, 
such as determining whether to merge or split Cochrane reviews, or to make recommendations relating to 
reporting of standard outcomes.   The differences in stated overview aims or purpose did not appear to 
fully explain the variations in methods between overviews, and the intended pathways to impact were 
generally unclear.  
There was evidence of uptake of academic outputs, with five of the seven overviews being in the top 5% of 
research outputs scored by Altmetric.  These Altmetric scores highlight that many overviews are being 
accessed as a result of social media dissemination, rather than by traditional journal publication only.  
However, it was noted that few of these overviews explicitly addressed the ways in which the overview 
could potentially support evidence-based rehabilitation.  Interpretation of this finding should be cautionary 
as the absence of reporting does not mean that overview authors did not consider the intended impact of 
the overview; arguably this may reflect use of the reporting template provided by Cochrane.  Given that 
Cochrane overviews are a relatively new product and that there is a known lack of guidance relating to 
methods and reporting of overviews,14, 16, 21, 25, 26 it is perhaps not surprising that there are variations within 
these  overviews in terms of the main approach to evidence synthesis and summary.   
We also carried out a more in-depth exploration relating to one particular overview, focussed on 
interventions to improve upper limb function after stroke, and charted evidence of activities and outputs 
which have potential to have a beneficial impact on outcomes for stroke survivors, through enhanced 
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support for decision making and informed practice and research.  Impact on stroke survivor outcomes – 
arguably the most important goal of the overview - is arguably one of the most difficult types of impact to 
capture and attribute, as it is dependent on multiple influences, such as patient preferences, staff skills and 
local resources, and would require complex evaluation processes using validated outcomes.      
If Cochrane overviews are to have a beneficial impact on evidence-based rehabilitation, it would appear 
crucial that careful consideration is given to how the overview will support this.  We believe that it would 
be advantageous to the facilitation of beneficial societal, economic and academic impacts from overviews if 
clear descriptions of impact goals, beneficiaries, and proposed pathways to impact were clearly and 
transparently stated within Cochrane overviews (and protocols for overviews).  We have proposed a 
generic map as a way to begin to support consideration and charting of potential pathways to impact, but 
this will require further development and refinement.  Integrating clearly stated impact goals, and 
proposing and implementing strategies designed to meet these goals, would be an important step towards 
ensuring that future overviews can support the delivery of evidence-based care.   
Given the broad range of populations who receive rehabilitation interventions, and the number of 
Cochrane reviews relevant to rehabilitation, it is apparent that the current Cochrane overviews only cover a 
very small proportion of potentially relevant topics.  However, overviews are a relatively new methodology 
and numbers are increasing; our search identified 11 protocols, some of which have now progressed to full 
overview (including overviews relevant to rehabilitation: see Supplementary Digital Material: Appendix 1).  
Exploration of Cochrane reviews relating to rehabilitation highlights that there are many “clusters” of 
reviews which could potentially be brought together within an overview in order to enhance accessibility to 
related evidence.  For example, future overviews could summarise evidence from “clusters” of reviews of: 
different interventions for specific topics, such as low back pain; single intervention for different 
populations, such as transcutaneous electrical stimulation; interventions or care delivered by one allied 
health professional group, such as speech and language therapy (see Supplementary Digital Material: 
Appendix 3, for three examples of “clusters” of Cochrane reviews). Evidence from the completed 
overviews, and knowledge of the existence of many clusters of Cochrane reviews, contribute to the 
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argument that Cochrane overviews could potentially play an important role in providing a “friendly front 
end” to evidence addressing a range of rehabilitation interventions for a particular population, condition or 
problem.  Such Cochrane overviews could clearly signpost the existing reviews, and increase accessibility 
and knowledge of this valuable evidence base. 
However, counter to this, healthcare decision makers already report feeling overwhelmed by the high and 
rapidly increasing numbers of research publications and it is crucial that production of overviews of reviews 
serve as a solution to this problem, rather than simply adding to the insurmountable volume of evidence.  
While overviews have been proposed to have a role in the avoidance of research waste there is clearly a 
risk that the opposite occurs, and overviews contribute to research waste, producing inaccessible and 
complex documents.  Printed versions of these seven rehabilitation overviews vary in length from 43-172 
pages, demonstrating that these are lengthy, rather than brief summary, documents; and our experience of 
reading and synthesising information from these overviews highlighted inconsistencies in reporting and 
lack of clear indexing which were barriers to accessibility.  Further, to be of use, evidence needs to be up-
to-date, and consequently it is important that overviews are maintained and updated, ensuring inclusion of 
and signposting to, the most up-to-date evidence.  Five of the seven overviews did nothing to update the 
included reviews, while the sixth identified recent randomised controlled trials but the authors found they 
were unable to incorporate these into the existing reviews.   Cochrane has recently introduced “Living 
systematic reviews” into the Cochrane Library;48 embarking on the development and maintenance of “living 
overviews” could be an important step toward efficient, timely overviews which remain useful and up-to-
date. 
Recommendations for future overviews  
Exploration of current overviews relating to rehabilitation highlights that there are variations in aims, 
methods, reporting and activities to support knowledge translation and impact.  It is essential that authors 
planning to conduct new overviews are aware of the rapidly evolving body of evidence and guidance 
relating to the conduct and reporting of overviews (e.g.16, 25, 29, 30) and use latest guidance to inform the 
selection of optimal methods.  It is important to remain cognisant of the fact that the objective of an 
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overview is to support knowledge translation, and therefore differs from the objective of an individual 
systematic review.  If overviews are to be accessible and useful, it is essential that key stakeholders are 
involved in identifying priority topics for overviews and planning and implementing bespoke knowledge 
translation strategies,11, 21, 49 tailored to their intended groups of beneficiaries.  Within Table V we propose a 
number of recommendations to help achieve a beneficial impact of future Cochrane overviews on 
evidence-based rehabilitation. 
Cochrane Rehabilitation, which is aimed at acting as a “bridge” between authors and users,31 is well-placed 
to support the development of future overviews which are purposefully designed to generate impact, i.e. 
relevant, useful and used.  Cochrane Rehabilitation may be able to facilitate and support input of key 
rehabilitation stakeholders internationally, ensuring representative contributions to key stages of the 
overview process.  For example, with international networks of key stakeholders, Cochrane Rehabilitation 
could contribute to the development and sharing template “summaries” for different groups of 
beneficiaries which could be adapted and evolved as further lessons are learnt from new overviews.  
Further, the Cochrane Rehabilitation Methodology committee33, 50 is ideally placed to support the 
development of consistent and high quality methods within rehabilitation overviews, promoting sharing of 
best practice between overview authors, and development of guidance and templates. 
CONCLUSION 
Cochrane overviews have the potential to play a key role in knowledge translation and therefore to have a 
beneficial impact on evidence based rehabilitation.  Current Cochrane overviews of rehabilitation 
interventions commonly summarise evidence from a range of related systematic reviews, but sometimes 
fall short of presenting key findings in an easily accessible format and clearly sign-posting readers to 
relevant sources of evidence.  To maximise the potential beneficial impact of future Cochrane overviews it 
is important that these address topics of importance to key beneficiaries, have clear pre-planned goals 
aimed at societal/economic as well as academic impact and clearly outline potential pathways to impact.  A 
generic map was proposed to assist authors of Cochrane overviews in charting their intended pathways to 
impact, which can be further developed as experience accumulates.  It is important that Cochrane 
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overviews present summary information in a succinct and accessible format, and are maintained up-to-
date.  In conclusion, high quality overviews addressing important rehabilitation topics, with carefully 
planned strategies to address impact goals, have the potential to have a beneficial impact on evidence-
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chronic pain in 
adults42 














13/04/13 55 71* - 3 posts 
from 3 
blogs 

















13/01/17 12 4 - - 7 - - 330$ 
Table IV: Summary of key access data for the included overviews 
*In the top 5% of all research outputs scored by Altmetric 




Goal.  Cochrane overviews should: Recommendation to achieve goal:  
Be designed to avoid research waste, addressing 
priority topics / research questions, which have a 
clear objective, and where there is a known body 
of Cochrane reviews. 
Key stakeholders should be involved in identifying 
priorities for Cochrane rehabilitation overviews. 
Clearly signpost readers to where there is 
evidence relating to the effect of specific 
interventions on important outcomes.   
A brief summary (e.g. maximum 2-sided page) 
specifically aimed at clearly summarising if there is 
evidence of interventions which are beneficial, and 
where more details are available.  This summary 
should be made freely available, easy to access by 
intended beneficiaries and easy to share.   
Authors are recommended to consult with their 
beneficiaries as to the optimum communication 
strategy/ strategies to facilitate uptake. 
Be relevant and accessible to all beneficiaries, 
including rehabilitation practitioners, 
commissioners, policy makers, educators, 
patients, caregivers and families.   
Involvement of key stakeholders in the overview 
process is recommended, particularly at the 
planning/protocol stage, and at the synthesis of 
evidence stage to facilitate knowledge translation 
and dissemination (see previous recommendation). 
Describe and implement pre-planned methods 
for identifying evidence gaps (only relevant where 
a Cochrane overview aims to inform future 
research)  
The methods for identification of evidence gaps and 
generation of research recommendations should be 
clearly described in the protocol/methods section. 
Be maintained up-to-date Authors should pre-plan strategies for regular 
updating of the overview, and consider options for 
creating a “living” overview. 
Authors should pre-plan strategies for what to do if 
the eligible reviews are out of date. 
Clearly state impact goals relating to societal, 
economic and academic impacts, beneficiaries 
and potential pathways to impact, including 
strategies for dissemination beyond publication 
of the overview within the Cochrane Library 
At the protocol stage, authors should clearly state 
impact goals and beneficiaries, with consideration of 
pathway to impact. 
Develop, with input from key stakeholders, a 
detailed knowledge translation strategy for the 
overview.  This should clearly address stated impact 
goals and identified pathways to impact. Publish this 
in the protocol/methods and implement this plan. 
Propose  methods aimed at capturing and 
evaluating impact of overviews 
Impact goals, and methods of evaluation, should be 
clearly identified within the protocol/methods. 
 













Pharmacology only (n=24) 




Protocol only (n=11) 




Figure 2: Pathway to impact 
 
